This comes amid reports of dangerous blood clots in some recipients
WHO said that it was still conducting its safety review of the AstraZeneca/Oxford Covid-19 vaccine as more European countries have suspended the use of this jab
An additional number of European countries -- France Germany, Italy, Spain, Slovenia, Cyprus, Portugal -- have also suspended the use of the AstraZeneca Covid-19 vaccine over blood clot concerns
The moves by some of Europe's largest and most populous countries will deepen concerns about the slow rollout of vaccines in the region
Several other European countries have temporarily halted use of the AstraZeneca vaccine in recent days to investigate cases of blood clots that occurred after vaccination
Business Standard brings you top news of the day
Several European countries have suspended the use of the vaccine
The Dutch authorities are halting the use of the AstraZeneca vaccine against the coronavirus amid concerns over recent blood clotting incidents
More European countries have suspended the use of the Covid-19 vaccine developed by AstraZeneca and University of Oxford following reports of several suspected deaths from clotting after inoculation
Tedros Adhanom Ghebreyesus, Director-General of the WHO said that the UN health agency systematically reviews safety signals, and is carefully assessing the current reports on the AstraZeneca vaccine
The British drugmaker completed enrollment in its trial of more than 32,000 volunteers in January and now has data on at least 150 cases of Covid-19
AstraZeneca said there was 'no evidence of an increased risk of blood clots, and European and UK medicines regulators have each said the link between the vaccine and blood clots has not been confirmed
Thailand, Bulgaria delay jab launch; WHO, France, Germany support shot
The precautionary move follows signals of a possible serious side effect in the form of 'deadly blood clots'
The move comes after one person in Denmark who was given the AstraZeneca shot formed a blood clot and died, the Danish Health Authority said
AstraZeneca Pharma India on Wednesday said it has received marketing approval from the Drugs Controller General of India (DCGI)for its product for the treatment of non-small cell lung cancer.
Govt must consider tweaking the norms and pricing
Almost 21 million shots have been administered in India so far, up from 5.4 million a month ago
Last week, Adar Poonawalla had said on a World Bank panel that a US law blocking the export of key items like bags and filters will likely cause "serious bottlenecks" in vaccine production
The EU executive backed Italy's decision to block a shipment of 250,000 doses of the AstraZeneca vaccine to Australia, European officials said